HCG (GMP)

HCG (GMP) — GMP Pharmaceutical Grade

HCG (GMP) is manufactured under strict Good Manufacturing Practice (GMP) pharmaceutical standards, ensuring absolute sterility, potency, and batch-to-batch consistency for clinical-grade research and application.

Pharmaceutical Specifications

Parameter	Value
Molecular Formula	C1105H1770N318O336S26
Molecular Mass	~36,700 Da
Quality Grade	GMP Pharmaceutical Grade
Appearance	Clear reconstituted solution

Figure 1: HCG (GMP) Clinical Mechanism

Clinical Mechanism of Action

Pharmaceutical-grade pathway delivering its primary therapeutic effect:

1. Serves as authentic, GMP-manufactured Human Chorionic Gonadotropin glycoprotein.
2. Directly mimics Luteinizing Hormone (LH) binding on gonadal Leydig cells.
3. Forces the immediate production and release of endogenous testosterone.
4. Maintains testicular volume and absolute spermatogenesis capacity during exogenous hormone use.
5. Prevents the catastrophic HPTA (Hypothalamic-Pituitary-Testicular Axis) shutdown.

Figure 2: Clinical Efficacy Metrics

Primary Clinical Outcomes

• Outcome 1: The universally required fertility preservation anchor during any external hormone administration.
• Outcome 2: GMP manufacturing ensures absolute sterility, accurate dosing, and zero contamination risk.
• Outcome 3: Maintains reproductive capacity for male subjects far beyond what standard compounded products achieve.

Human Chorionic Gonadotropin: Endocrine Function

HCG is a glycoprotein hormone composed of an alpha subunit (shared with LH, FSH, and TSH) and a unique beta subunit that confers its biological specificity. In reproductive physiology, HCG is secreted by trophoblast cells following embryo implantation and is the primary marker detected by pregnancy tests. Its structural similarity to luteinizing hormone (LH) allows it to bind to LH/CG receptors in gonadal tissue, stimulating steroidogenesis in both male and female models.

1. HCG binds to LH/CG receptors on Leydig cells in testicular tissue, stimulating testosterone biosynthesis via the cholesterol side-chain cleavage (P450scc) pathway.
2. In ovarian tissue, HCG maintains corpus luteum function during early gestation, sustaining progesterone output until placental steroidogenesis is established.
3. The glycosylation pattern of GMP-grade HCG ensures consistent receptor binding affinity and predictable pharmacokinetics across lots.
4. Half-life of intact HCG is approximately 24–36 hours, with the beta subunit cleared renally over 48–72 hours.
5. Research applications include ovulation induction models, testosterone restoration studies, and cryptorchidism investigation in pediatric endocrinology.

GMP Manufacturing Standards

• Facility Certification: Produced in ISO 14644-1 Class 7 (Class 10,000) cleanrooms under current Good Manufacturing Practice (cGMP) guidelines.
• Potency Verification: Each lot undergoes a bioassay confirming IU potency against the WHO International Standard for HCG (IS 99/688).
• Endotoxin Testing: Limulus Amebocyte Lysate (LAL) testing confirms endotoxin levels below 5 EU/mL, meeting injectable-grade specifications.
• Sterility Assurance: Terminal sterilization by 0.22 μm filtration followed by sterility testing per USP <71> (14-day incubation in TSB and FTM media).
• Cold Chain: Shipped on ice packs and must be refrigerated (2–8°C) upon receipt. Reconstituted solutions remain stable for 30 days refrigerated.